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Abstract
We report a case of 71-year-old female patient, previously treated with chemotherapy and surgical resection of sigmoid tract 
of the large bowel for adenocarcinoma (pT3N1M0), who underwent a 18F-FDG PET/CT for a suspicious hepatic lesion detected 
at CT scan during follow-up. 18F-FDG PET/CT showed no abnormal uptake in the liver both at 60 minutes and 120 minutes 
after injection but revealed a pathological uptake in two breast nodules, (one localized in upper-internal-quadrant of the right 
breast and the other in the upper-external-quadrant of the left breast). The patient underwent breast MRI, which confirmed the 
suspicious nature of both lesions; subsequently she underwent a trucut biopsy of both lesions witch demonstrated a bilateral 
localization of papillary carcinoma (both lesion were classified as pT1c). The patient underwent bilateral mastectomy and the 
final biopsy confirmed the presence of breast cancer, while bilateral sentinel nodes biopsy showed no lymph-nodes metastases.
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Background
Incidental and unexpected focal 18F-fluoro-2-deoxyglucose 
(18F-FDG) uptakes in many organs are relatively frequent and can 
involve many organs as thyroid [1, 2], prostate [2], parotid gland 
[3] and colon [4]. Breast incidentaloma is commonly considered 
a breast lesion incidentally and newly detected by imaging tech-
niques performed for an unrelated purpose and especially not for 
investigating breast diseases. Moreover, unexpected focal 18F-FDG 
uptakes can involve breast frequently revealing an unexpected 
breast cancer [5–8]; this means that, despite screening proce-
dures, some lesions are still missed during traditional screening 
and could be incidentally revealed by 18F-FDG positron emission 
tomography (PET).
Case report
A 71-year-old female patient previously treated with chemother-
apy and surgical resection of sigmoid tract of the large bowel for ad-
enocarcinoma (pT3, N1, M0) underwent a CT scan during follow-up 
which was doubtful for a secondary lesion in the VII segment of the 
liver. 18F-FDG PET/CT was performed after intravenous administra-
tion of 3.5 MBq/kg; total body images were acquired 60 minutes af-
ter injection on Discovery ST tomograph (GE — Milwaukee, Wi, 
USA; 4-slice-CT, 80mA, 120Kv; 3 minutes PET-bed; 128 × 128 ma-
trix, 60 cm field of view) and further abdominal images were also 
acquired after 120 minutes from injection. The study showed no 
pathological uptake in the liver both after 60 and 120 minutes but 
revealed unexpected pathological uptakes in two breast nodules: 
one localized in the upper-inner-quadrant (UIQ) of the right breast 
and the other in the upper-external-quadrant of the left breast (UEQ). 
(Figure 1). The subsequent bilateral mammography confirmed the 
lesions described with PET/CT, particularly one lesion in the UIQ 
of the right breast next to the areola with a diameter of 30 mm, 
the other about 15 mm in the UEQ of the left breast. To study in 
deep the nature of these lesions the patient underwent breast MRI, 
which confirmed the suspicious features of both nodules (Figure 2). 
Afterwards she performed a trucut biopsy of the lesions which 
showed a bilateral localization of papillary carcinoma (both le-
sion were classified as pT1c) (Figure 3). Subsequently the patient 
underwent to bilateral mastectomy and the biopsy confirmed the 
presence of breast cancer, while bilateral sentinel nodes biopsy 
showed no lymph-nodes metastases.
Discussion
In patients affected by cancer workups usually focus on the 
patient’s primary disease, and incidental coexistence of another 
primary malignant lesion can be missed. The singularity of this case 
is the bilateral breast incidentaloma histologically confirmed 
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Figure 1A–G. Axial CT (A), axial PET (B) and fused images (C) of the right breast nodule showing a focal area 
of FDG uptake in the UIQ; axial CT (D), axial PET (E) and fused images (F) of left breast nodule showing a focal 
area of FDG uptake in UEQ and maximum intensity projection image of the body after 60 minutes (G)
Figure 2A–F. Mammography: craniocaudal view (A) and mediolateral view (B) showing discrete area  
of densification of 28 × 8 mm in the upper-inner-quadrant (UIQ) in the para-areolar region of right breast; 
craniocaudal view (C) and mediolateral view (D) showing parenchymal opacity with irregular pattern of about 
15 mm in the upper-external-quadrant (UEQ) of left breast. Axial MRI images reveal multiple areas of nodular 
contrast enhancement involving the right breast in UIQ which reaches up to 7–8 mm from the nipple (E) and 
a single area of nodular contrast enhancement involving the left breast in UEQ (F)
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as cancer; to best of our knowledge this is the first reported case 
in literature discovered with 18F-FDG PET/CT. 18F-FDG PET/CT 
is not currently recommended for primary breast cancer detection 
because of high false negative rates in the presence of small early 
breast cancer. Low sensitivity was described for the identification 
of small non-palpable (< 1 cm) and low-grade malignancies [9] 
but it showed an added value in the detection of loco regional re-
currence or distant metastases in locally advanced breast cancer 
[10]. Since screening procedure for breast cancer started a reduc-
tion of mortality was observed and an extension of lives despite 
the overdiagnosis still represents a problem. Despite screening 
procedure for breast cancer the data available in literature report 
a small number of incidental breast uptakes in patients studied 
with 18F-FDG PET/CT for non-breast-related oncological reasons, 
which suggest that some lesions are still missed during traditional 
screening procedures [5–8]. In differentiating benign from malignant 
lesion SUVmax values showed a low accuracy and a cut-off value 
couldn’t be considered [6, 7]. A recently published revision of the 
literature suggest that prevalence of hypermetabolic lesions in the 
breast is between 0.36 and 1.84% and overall risk of malignancy 
is between 18 and 100% [6]. This case report suggests that every 
breast uptake need further imaging in order to rule out malignancy. 
Despite being not frequent, breast incidentalomas are clinically 
relevant showing a high percentage of malignancy and, therefore, 
need further investigation.
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Figure 3A–C. H&E-stained section (A) shows multiple neoplastic nodules composed of epithelial cells growing 
in a solid pattern with fibrovascular cores among the solid cellular proliferation. Calponin immunostaining 
demonstrates absence of myoepithelial cell within the cellular proliferation (B), highlighting the focal residual 
myoepithelial cells at the periphery of some neoplastic nodules (C)
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